Cargando…
An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors
The judicious application of ligand or binding efficiency (LE) metrics, which quantify the molecular properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads. Here we report for the first time the use of LE b...
Autores principales: | Xue, Xin, Bao, Gang, Zhang, Hai-Qing, Zhao, Ning-Yi, Sun, Yuan, Zhang, Yue, Wang, Xiao-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321222/ https://www.ncbi.nlm.nih.gov/pubmed/30513790 http://dx.doi.org/10.3390/molecules23123174 |
Ejemplares similares
-
Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
por: Beloglazkina, Anastasia, et al.
Publicado: (2020) -
Small-Molecule Inhibitors
of the MDM2–p53 Protein–Protein
Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
por: Zhao, Yujun, et al.
Publicado: (2014) -
Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
por: Blackburn, Tim J., et al.
Publicado: (2013) -
Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci
por: Frosi, Y., et al.
Publicado: (2019) -
α-Helix-Mimicking
Sulfono-γ-AApeptide
Inhibitors for p53–MDM2/MDMX Protein–Protein Interactions
por: Sang, Peng, et al.
Publicado: (2020)